ProPharma is at the forefront of the life sciences industry and continues to innovate and elevate its position as the world’s largest RCO. Stay up to date on ProPharma’s latest news and most recent announcements.
Clinical Research Solutions
ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Diamond Pharma Services. Diamond Pharma Services provides regulatory affairs, pharmacovigilance, and...
Clinical Research Solutions
DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...
Clinical Research Solutions
Odyssey Investment Partners ("Odyssey") announced today that it has entered into an agreement to acquire ProPharma Group (or the "Company") from Linden Capital Partners. Financial terms of the...
Clinical Research Solutions
Linden Capital Partners (“Linden”), a Chicago-based private equity firm focused exclusively on the healthcare sector, announced an agreement to sell ProPharma Group (the “Company”) to Odyssey...
Clinical Research Solutions
ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Southwood Research. Based in Buckinghamshire, United Kingdom, Southwood Research is a leading provider of...
Clinical Research Solutions
Overland Park, KS — ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Washington D.C.-based The Weinberg Group Inc. The Weinberg Group is a leading...
Clinical Research Solutions
ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Washington D.C.-based The Weinberg Group Inc. The Weinberg Group is a leading provider of regulatory and...
Clinical Research Solutions
WASHINGTON, DC – OCTOBER 3, 2018 – The Weinberg Group (now ProPharma Group), is growing. In addition to people, the company has also expanded its capabilities. Building upon its role as the most...
Clinical Research Solutions
ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of SOLUTIONS in Health Inc., a Canada-based provider of medical information services to the pharmaceutical,...
Clinical Research Solutions
RALEIGH, NC, December 6, 2023 – ProPharma Group (ProPharma), the world’s largest Research Consulting Organization (RCO) and the leading global provider of regulatory, clinical and compliance services...
Clinical Research Solutions
RALEIGH, NC, April 3, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry and a portfolio company of Odyssey...
Clinical Research Solutions
$50m investment and rebrand unveiled at J.P. Morgan Healthcare Conference as part of new global growth strategy. RALEIGH, NC, January 9, 2023: ProPharma Group – the end-to-end, global provider of...
Clinical Research Solutions
ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Diamond Pharma Services. Diamond Pharma Services provides regulatory affairs, pharmacovigilance, and...
Clinical Research Solutions
ProPharma Group and The Planet Group have reached a definitive agreement to merge the two companies. ProPharma Group, a portfolio company of Odyssey Investment Partners, is the leading global...
Quality & Compliance
First-of-its-kind Cell Factory Box streamlines production, making advanced treatments accessible and affordable RALEIGH, May 2, 2024 – ProPharma, the leading global provider of regulatory, clinical,...